Difficulty: Medium
Average Score: 69%
Practice
A client with chronic kidney disease (CKD) is receiving erythropoietin therapy. What is the primary purpose of this medication?
Correct answer
C
Rationale
The correct answer is C: 'To increase red blood cell production.' Erythropoietin stimulates the production of red blood cells to treat anemia associated with CKD. Choices A, B, and D are incorrect because erythropoietin therapy is primarily used to address anemia by increasing the production of red blood cells rather than lowering blood pressure, improving appetite, or reducing fluid retention.